InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
17,020.00
(
0.94%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
84.03
(
0.58%
)
Bitcoin
57,743.80
(
-0.85%
)
Post# of 251673
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

puravida

Send PM Follow Ignore
Followers 36
Posts 1736
Boards Moderated 0
Alias Born 05/13/2011

puravida

Re: None

Monday, 05/04/2020 8:51:09 AM

Monday, May 04, 2020 8:51:09 AM

Post# of 251673

Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market
Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies

Total potential consideration of $12.50 per share comprising $11.50 cash and $1.00Contingent Value Right (CVR)


https://ir.stemline.com/news-releases/news-release-details/menarini-group-acquire-stemline-therapeutics-transaction-valued
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up